文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

了解原发性头痛的延误诊断和诊断转变:来自日本医疗保险理赔的证据。

Understanding Delays and Diagnostic Shifts in Primary Headaches: Evidence from Japanese Health Insurance Claims.

作者信息

Tatsuno Yuki, Katsuki Masahito, Kawata Yumi, Takeshima Takao

机构信息

Medical Affairs, Hedgehog MedTech, Inc, Tokyo, JPN.

Insight Science Foundation Ireland Research Centre for Data Analytics, School of Human and Health Performance, Dublin City University, Dublin, IRL.

出版信息

Cureus. 2025 May 28;17(5):e85005. doi: 10.7759/cureus.85005. eCollection 2025 May.


DOI:10.7759/cureus.85005
PMID:40585590
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12206065/
Abstract

Introduction The early and accurate diagnosis of primary headaches is essential for improving patients' quality of life and preventing the overuse of acute medications. Lack of a proper diagnosis not only reduces the patients' quality of life but also may result in patients having to return to other medical facilities or undergo duplicate tests, which has a negative impact on the health care system, including increasing medical costs. In Japan, although primary headaches are prevalent, studies investigating the misdiagnosis and underdiagnosis of headaches are limited. This study aimed to explore current trends in primary headache diagnosis and investigate how these diagnoses changed during the five years following the initial diagnosis. Methods We used an anonymized, nationwide health insurance claim database from Japan, which contained data from July 2010 through November 2024. We included the outpatient claim data of adults aged 18 years or older. Using the International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10), we classified headache diagnoses into five categories: migraine and medication-overuse headaches (MOHs), tension-type headaches (TTHs), trigeminal autonomic cephalalgia (TACs), other primary headaches, and other headaches including secondary headaches. Cases with no specific headache diagnosis based on the ICD-10 were classified as unconfirmed. We assessed diagnostic consistency between the initial diagnosis and 3, 6, 12, 36, and 60 months later. Results We analyzed data from 336,596 patients. The mean (SD) age was 40.2 (12.3) years. Overall, 91,830 patients (27.3%) were men and 244,766 (72.7%) were women. Regarding the initial diagnoses, 95,890 (28.5%) were unconfirmed diagnoses, 181,651 (54.0%) were migraine or MOH, 56,296 (16.7%) were TTH, 853 (0.3%) were TACs, 1,663 (0.5%) were other primary headaches, and 243 (0.1%) were other headaches. Of the 86,164 patients (25.6%) who had a definitive headache diagnosis three to five years after their initial visit, 51,360 (59.6%) received the same diagnosis at their initial visit and subsequent visit. The most common headache diagnosis after three to five years was migraine or MOH (n=67,939; 78.8%), followed by TTH (n=17,371; 20.2%), other primary headaches (n=488; 0.6%), TACs (n=307; 0.4%), and other headaches (n=59; 0.07%). The most frequent diagnostic change was from a TTH diagnosis to a migraine or MOH diagnosis (n=2,522; 2.9%). Conclusions Over one in four patients received an unconfirmed diagnosis during their initial visit and more than 40% of patients were given different diagnoses during a later follow-up. These findings indicate the challenges and delays associated with reaching a definitive diagnosis for primary headaches.

摘要

引言 原发性头痛的早期准确诊断对于提高患者生活质量和防止急性药物的过度使用至关重要。缺乏正确诊断不仅会降低患者的生活质量,还可能导致患者不得不返回其他医疗机构或接受重复检查,这会对医疗保健系统产生负面影响,包括增加医疗成本。在日本,尽管原发性头痛很普遍,但关于头痛误诊和漏诊的研究有限。本研究旨在探讨原发性头痛诊断的当前趋势,并调查这些诊断在初次诊断后的五年内如何变化。 方法 我们使用了来自日本的匿名全国健康保险理赔数据库,其中包含2010年7月至2024年11月的数据。我们纳入了18岁及以上成年人的门诊理赔数据。使用《国际疾病和相关健康问题统计分类》第十次修订版(ICD-10),我们将头痛诊断分为五类:偏头痛和药物过量使用性头痛(MOH)、紧张型头痛(TTH)、三叉自主神经性头痛(TAC)、其他原发性头痛以及包括继发性头痛在内的其他头痛。根据ICD-10没有特定头痛诊断的病例被分类为未确诊。我们评估了初次诊断与3个月、6个月、12个月、36个月和60个月后的诊断一致性。 结果 我们分析了336,596名患者的数据。平均(标准差)年龄为40.2(12.3)岁。总体而言,91,830名患者(27.3%)为男性,244,766名患者(72.7%)为女性。关于初次诊断,95,890例(28.5%)为未确诊诊断,181,651例(54.0%)为偏头痛或MOH,56,296例(16.7%)为TTH,853例(0.3%)为TAC,1,663例(0.5%)为其他原发性头痛,243例(0.1%)为其他头痛。在初次就诊三至五年后有明确头痛诊断的86,164名患者(25.6%)中,51,360例(59.6%)在初次就诊和后续就诊时得到相同诊断。三至五年后最常见的头痛诊断是偏头痛或MOH(n = 67,939;78.8%),其次是TTH(n = 17,371;20.2%)、其他原发性头痛(n = 488;0.6%)、TAC(n = 307;0.4%)和其他头痛(n = 59;0.07%)。最常见的诊断变化是从TTH诊断变为偏头痛或MOH诊断(n = 2,522;2.9%)。 结论 超过四分之一的患者在初次就诊时接受了未确诊诊断,超过40%的患者在后续随访中得到了不同的诊断。这些发现表明了原发性头痛明确诊断所面临的挑战和延迟。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76bd/12206065/2e0fda1067ac/cureus-0017-00000085005-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76bd/12206065/2e0fda1067ac/cureus-0017-00000085005-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76bd/12206065/2e0fda1067ac/cureus-0017-00000085005-i01.jpg

相似文献

[1]
Understanding Delays and Diagnostic Shifts in Primary Headaches: Evidence from Japanese Health Insurance Claims.

Cureus. 2025-5-28

[2]
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.

Syst Rev. 2024-11-26

[3]
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.

Cochrane Database Syst Rev. 2020-10-19

[4]
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Cochrane Database Syst Rev. 2022-5-20

[5]
Aspirin for acute treatment of episodic tension-type headache in adults.

Cochrane Database Syst Rev. 2017-1-13

[6]
Botulinum toxins for the prevention of migraine in adults.

Cochrane Database Syst Rev. 2018-6-25

[7]
Psychological therapies for treatment-resistant depression in adults.

Cochrane Database Syst Rev. 2018-5-14

[8]
Noninvasive Vagus Nerve Stimulation for Cluster Headache and Migraine: A Health Technology Assessment.

Ont Health Technol Assess Ser. 2025-5-1

[9]
Paracetamol (acetaminophen) for acute treatment of episodic tension-type headache in adults.

Cochrane Database Syst Rev. 2016-6-16

[10]
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Cochrane Database Syst Rev. 2021-4-19

本文引用的文献

[1]
Healthcare resource use and costs associated with the misdiagnosis of migraine.

Headache. 2025-1

[2]
Validation and comparison of the coding algorithms to identify people with migraine using Japanese claims data.

Front Neurol. 2023-11-27

[3]
Economic burden of chronic migraine in OECD countries: a systematic review.

Health Econ Rev. 2023-9-1

[4]
Status of diagnosis and preventative treatment for primary headache disorders: real-world data of unmet needs in China.

J Headache Pain. 2023-9-1

[5]
Risk factors for migraine disease progression: a narrative review for a patient-centered approach.

J Neurol. 2023-12

[6]
Debate: differences and similarities between tension-type headache and migraine.

J Headache Pain. 2023-7-21

[7]
Developing an artificial intelligence-based headache diagnostic model and its utility for non-specialists' diagnostic accuracy.

Cephalalgia. 2023-5

[8]
Headache education by leaflet distribution during COVID-19 vaccination and school-based on-demand e-learning: Itoigawa Geopark Headache Awareness Campaign.

Headache. 2023-3

[9]
The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates.

J Headache Pain. 2022-4-12

[10]
Disability, quality of life, productivity impairment and employer costs of migraine in the workplace.

J Headache Pain. 2021-4-21

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索